Abstract 4449: Hepatic steatosis induced by bioactive lipids
Abstract Introduction: HCC is the most common form of liver cancer and is the sixth most common cancer globally. Despite the clinical advancement of immune checkpoint inhibitors, median survival continues to be less than twenty months and most patients develop resistance making it one of the deadlie...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 84; no. 6_Supplement; p. 4449 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
22.03.2024
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Introduction: HCC is the most common form of liver cancer and is the sixth most common cancer globally. Despite the clinical advancement of immune checkpoint inhibitors, median survival continues to be less than twenty months and most patients develop resistance making it one of the deadliest malignancies. The rate of liver cancer continues to rise, which is coupled to the high prevalence of steatosis and steatohepatitis that accounts for about 25% in the general population. Pathologically, 80% of liver cancer occurs in patients with an underlying liver disease that displays liver steatosis. Thus, it is paramount to better characterize the transition from steatosis to HCC.
Methods: Utilizing a Pten deleted mouse model (PtenloxP/loxP; Alb-Cre+) that recapitulates HCC progression, protein and lipid fractions were isolated to explore differentially expressed proteins and their correlations with bioactive lipid metabolism. Global untargeted differential proteomics was done with fractionation using a qExactive. Lipid fractions were analyzed using a Sciex 6500 for targeted lipidomic analysis. In addition, genetic knockout hepatocyte cell lines of each AKT isoform were used to explore the involvement of the PI3K/AKT signal. Further, a phosphoproteomic enrichment was performed to discover downstream signaling targets.
Results: The PTEN regulated PI3K/AKT signal is induced in 54% of all liver cancers and represents the dominant signaling pathway regulating liver cancer progression. Untargeted differential proteomic analysis of Pten deleted mice livers revealed significant dysregulation in oxidative stress and eicosanoid metabolism among the top enriched disease and biological functions when the phenotype progressed from steatosis to HCC. Analysis of publicly available liver cancer patient samples from the NCI Proteomic Data Commons further shows strong correlation between PTEN protein abundance and the expression of enzymes involved in eicosanoid metabolism. Our analysis using a bio-active lipid multi reaction monitoring panel of Pten deleted mouse livers further validates significant decreases in resolving eicosanoid levels along with increases in proinflammatory eicosanoid precursors as steatosis progress to HCC. These data suggest a potential hepatic AKT-dependency in regulating the shift towards proinflammatory eicosanoids. Primary isolated hepatocytes from mouse livers lacking either AKT1 or AKT2 were analyzed to elucidate AKT’s regulatory role in hepatic eicosanoid metabolism. Proteomic and lipidomic analysis of these hepatocytes supported a unique AKT isoform specific role in the regulation of eicosanoids via potential isoform specific signaling interactions with MAPK.
Conclusion: Eicosanoid metabolism dysregulation plays a key role in the progression from steatosis to HCC and appears to be regulated in an AKT isoform specific manner via interactions with MAPK signaling.
Citation Format: Mario Alba, Ielyzaveta Slarve, Brandon Ebright, Yiren Zhou, Whitaker Cohn, Yunyi Jia, Elizabeth Elton, Jared Khan, Aditi Datta, Lina He, Qi Tang, Pranav Pammidimukkala, Taojian Tu, Phillip Nguyen, Jonathan Katz, Julian Whitelegge, Stan Louie, Bangyan Stiles. Hepatic steatosis induced by bioactive lipids [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4449. |
---|---|
AbstractList | Abstract
Introduction: HCC is the most common form of liver cancer and is the sixth most common cancer globally. Despite the clinical advancement of immune checkpoint inhibitors, median survival continues to be less than twenty months and most patients develop resistance making it one of the deadliest malignancies. The rate of liver cancer continues to rise, which is coupled to the high prevalence of steatosis and steatohepatitis that accounts for about 25% in the general population. Pathologically, 80% of liver cancer occurs in patients with an underlying liver disease that displays liver steatosis. Thus, it is paramount to better characterize the transition from steatosis to HCC.
Methods: Utilizing a Pten deleted mouse model (PtenloxP/loxP; Alb-Cre+) that recapitulates HCC progression, protein and lipid fractions were isolated to explore differentially expressed proteins and their correlations with bioactive lipid metabolism. Global untargeted differential proteomics was done with fractionation using a qExactive. Lipid fractions were analyzed using a Sciex 6500 for targeted lipidomic analysis. In addition, genetic knockout hepatocyte cell lines of each AKT isoform were used to explore the involvement of the PI3K/AKT signal. Further, a phosphoproteomic enrichment was performed to discover downstream signaling targets.
Results: The PTEN regulated PI3K/AKT signal is induced in 54% of all liver cancers and represents the dominant signaling pathway regulating liver cancer progression. Untargeted differential proteomic analysis of Pten deleted mice livers revealed significant dysregulation in oxidative stress and eicosanoid metabolism among the top enriched disease and biological functions when the phenotype progressed from steatosis to HCC. Analysis of publicly available liver cancer patient samples from the NCI Proteomic Data Commons further shows strong correlation between PTEN protein abundance and the expression of enzymes involved in eicosanoid metabolism. Our analysis using a bio-active lipid multi reaction monitoring panel of Pten deleted mouse livers further validates significant decreases in resolving eicosanoid levels along with increases in proinflammatory eicosanoid precursors as steatosis progress to HCC. These data suggest a potential hepatic AKT-dependency in regulating the shift towards proinflammatory eicosanoids. Primary isolated hepatocytes from mouse livers lacking either AKT1 or AKT2 were analyzed to elucidate AKT’s regulatory role in hepatic eicosanoid metabolism. Proteomic and lipidomic analysis of these hepatocytes supported a unique AKT isoform specific role in the regulation of eicosanoids via potential isoform specific signaling interactions with MAPK.
Conclusion: Eicosanoid metabolism dysregulation plays a key role in the progression from steatosis to HCC and appears to be regulated in an AKT isoform specific manner via interactions with MAPK signaling.
Citation Format: Mario Alba, Ielyzaveta Slarve, Brandon Ebright, Yiren Zhou, Whitaker Cohn, Yunyi Jia, Elizabeth Elton, Jared Khan, Aditi Datta, Lina He, Qi Tang, Pranav Pammidimukkala, Taojian Tu, Phillip Nguyen, Jonathan Katz, Julian Whitelegge, Stan Louie, Bangyan Stiles. Hepatic steatosis induced by bioactive lipids [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4449. |
Author | Datta, Aditi Pammidimukkala, Pranav Ebright, Brandon Slarve, Ielyzaveta Jia, Yunyi Louie, Stan Whitelegge, Julian Tang, Qi He, Lina Alba, Mario Khan, Jared Zhou, Yiren Elton, Elizabeth Nguyen, Phillip Tu, Taojian Stiles, Bangyan Katz, Jonathan Cohn, Whitaker |
Author_xml | – sequence: 1 givenname: Mario surname: Alba fullname: Alba, Mario – sequence: 2 givenname: Ielyzaveta surname: Slarve fullname: Slarve, Ielyzaveta – sequence: 3 givenname: Brandon surname: Ebright fullname: Ebright, Brandon – sequence: 4 givenname: Yiren surname: Zhou fullname: Zhou, Yiren – sequence: 5 givenname: Whitaker surname: Cohn fullname: Cohn, Whitaker – sequence: 6 givenname: Yunyi surname: Jia fullname: Jia, Yunyi – sequence: 7 givenname: Elizabeth surname: Elton fullname: Elton, Elizabeth – sequence: 8 givenname: Jared surname: Khan fullname: Khan, Jared – sequence: 9 givenname: Aditi surname: Datta fullname: Datta, Aditi – sequence: 10 givenname: Lina surname: He fullname: He, Lina – sequence: 11 givenname: Qi surname: Tang fullname: Tang, Qi – sequence: 12 givenname: Pranav surname: Pammidimukkala fullname: Pammidimukkala, Pranav – sequence: 13 givenname: Taojian surname: Tu fullname: Tu, Taojian – sequence: 14 givenname: Phillip surname: Nguyen fullname: Nguyen, Phillip – sequence: 15 givenname: Jonathan surname: Katz fullname: Katz, Jonathan – sequence: 16 givenname: Julian surname: Whitelegge fullname: Whitelegge, Julian – sequence: 17 givenname: Stan surname: Louie fullname: Louie, Stan – sequence: 18 givenname: Bangyan surname: Stiles fullname: Stiles, Bangyan |
BookMark | eNqdjkELgjAcxUcYpNVHCPYFtE03sugiUXjp1n3MOWFhKvuvwG9fo4jOnd7j8R7vF6Gg6zuN0IqShFKerynP8njDGE-Kc0pSFjPGthMUfvPgx89QBHAlhHBKeIj2RQXOSuWwH-1wqQfpjMLgtHQ9GMCmq-9K17gacWX6V9M8NG7NYGpYoGkjW9DLj84RPx0vhzJWtgewuhGDNTdpR0GJ8KjCYwiPId6owr9m_-6ejPVIhg |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1158/1538-7445.AM2024-4449 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 4449 |
ExternalDocumentID | 10_1158_1538_7445_AM2024_4449 |
GroupedDBID | --- -ET 18M 29B 34G 39C 476 53G 5GY 5RE 6J9 AAJMC AAYXX ABOCM ACGFO ACIWK ACPRK ADBBV ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 W2D WH7 WOQ YKV YZZ |
ID | FETCH-crossref_primary_10_1158_1538_7445_AM2024_44493 |
ISSN | 1538-7445 |
IngestDate | Thu Sep 26 19:41:36 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6_Supplement |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1158_1538_7445_AM2024_44493 |
ParticipantIDs | crossref_primary_10_1158_1538_7445_AM2024_4449 |
PublicationCentury | 2000 |
PublicationDate | 2024-03-22 |
PublicationDateYYYYMMDD | 2024-03-22 |
PublicationDate_xml | – month: 03 year: 2024 text: 2024-03-22 day: 22 |
PublicationDecade | 2020 |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationYear | 2024 |
SSID | ssj0005105 |
Score | 4.6106057 |
Snippet | Abstract
Introduction: HCC is the most common form of liver cancer and is the sixth most common cancer globally. Despite the clinical advancement of immune... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 4449 |
Title | Abstract 4449: Hepatic steatosis induced by bioactive lipids |
Volume | 84 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwEA9zgvgifuI3efBttK5duq7iy5TJVCYIE4YvJUlTVijrGO1g-zf8h81XP5hDnC-lDeSS9n69y13uLgDctMN2iANsGbaLqYECyv-5JkUGaTVDoaDDUJ4SMXhr9z_Qy8gZ1WpflailLCUmXa7NK_kPV3kb56vIkt2AswVR3sDvOX_5lXOYX__E4y4RjgqaNhBCnrDt-2wqK7AK1qWJqDXCTe6MqlUmiRIspVsjjqaRSvCtFCmgbNbQpX_Gcm9XBWlIIRLHZtVlEBOs83xUFJdysuLZXHpHn1m8WOI5SwuJ3yOFD-CB68ag3Pr_HCeZ1AJRnpOmPRA2EiFYtr0iNF2kykKabE2blrTqMDiNqLYvzy0tA3yUBBUfrKKN88efkt4R2QvFMGZ3IKdWdq9W1l7ReEUcorSAnI4vyPiCjK_I-ILMFti2Xc8RFv3re1mC3lFxscXIOi2Mk7ldO5vKgqeychnugz1tcsCuws8BqLHJIdgZ6KCKI3CfwwgKQndQgwgWIIIaRJAsYAEiqEB0DJyn3vCxb-Sj-1NVv8T_9a1bJ6A-SSbsFEC3FXQC5nnUCz1kWS4JrNDuMGw1MXG54XsGzM1on2_a4QLsloC7BPV0lrErvghMybVkyjfqAFYK |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+4449%3A+Hepatic+steatosis+induced+by+bioactive+lipids&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Alba%2C+Mario&rft.au=Slarve%2C+Ielyzaveta&rft.au=Ebright%2C+Brandon&rft.au=Zhou%2C+Yiren&rft.date=2024-03-22&rft.issn=1538-7445&rft.eissn=1538-7445&rft.volume=84&rft.issue=6_Supplement&rft.spage=4449&rft.epage=4449&rft_id=info:doi/10.1158%2F1538-7445.AM2024-4449&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1538_7445_AM2024_4449 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1538-7445&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1538-7445&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1538-7445&client=summon |